[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638391":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":43,"centralContacts":52,"locations":58,"responsibleParty":345,"collaborators":43,"id":347,"slug":348,"hasResults":349,"nctId":350,"briefTitle":351,"officialTitle":352,"acronym":353,"eligibilityCriteria":354,"healthyVolunteers":349,"sex":355,"minAge":356,"maxAge":357,"enrollmentInfo":358,"targetDuration":43,"studyType":361,"phases":362,"briefSummary":365,"conditions":366,"keywords":368,"overallStatus":74,"whyStopped":43,"lastUpdateSubmitDate":375,"lastUpdatePostDateStruct":376,"startDateStruct":379,"completionDateStruct":381,"leadSponsor":383,"locationsCount":384},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8,16,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Sub study 1 Part A (SS1A): escalating dose levels of AZD9574 in combination with AZD2265 (FPI-2265)","EXPERIMENTAL","Participants will receive escalating dose levels of AZD9574 once daily in combination with AZD2265 (FPI-2265) once every 6 weeks (Q6W).",[13,14,15],"Drug: AZD2265 (FPI-2265)","Drug: AZD9574","Drug: AZD2287 (Imaging agent)",{"label":17,"type":10,"description":18,"interventionNames":19},"Sub study 1 Part B (SS1B): selected dose of AZD9574 in combination with AZD2265 (FPI-2265)","Participants will receive AZD9574 chosen from the DE phase once daily in combination with AZD2265 (FPI-2265) Q6W.",[13,14,15],{"label":21,"type":10,"description":22,"interventionNames":23},"SS1B: AZD2265 (FPI-2265) monotherapy","Participants will receive AZD2265 (FPI-2265) monotherapy Q6W.",[13,15],{"label":25,"type":26,"description":27,"interventionNames":28},"SS1B: Docetaxel","ACTIVE_COMPARATOR","Participants will receive docetaxel as a standard of care (SoC) once every 3 weeks (Q3W).",[29,15],"Drug: Docetaxel",[31,39,44,48],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","AZD2265 (FPI-2265)","AZD2265 (FPI-2265) will be administered as an intravenous (IV) injection.",[21,9,17],[37,38],"FPI-2265","225Ac-PSMA-I&T",{"type":32,"name":40,"description":41,"armGroupLabels":42,"otherNames":43},"AZD9574","AZD9574 will be administered orally.",[9,17],null,{"type":32,"name":45,"description":46,"armGroupLabels":47,"otherNames":43},"Docetaxel","Docetaxel will be administered as an IV infusion.",[25],{"type":32,"name":49,"description":50,"armGroupLabels":51,"otherNames":43},"AZD2287 (Imaging agent)","AZD2287 will be administered as an IV injection.",[21,25,9,17],[53],{"name":54,"role":55,"phone":56,"phoneExt":43,"email":57},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[59,73,82,91,99,108,117,126,134,143,152,162,172,180,188,196,206,214,222,227,235,244,249,254,259,264,274,282,290,295,303,313,321,329,337],{"facility":60,"status":61,"city":62,"state":63,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":43},"Research Site","NOT_YET_RECRUITING","Encino","California","91436","United States","US",{"type":68,"coordinates":69},"Point",[70,71],-118.50119,34.15917,{"lat":71,"lon":70},{"facility":60,"status":74,"city":75,"state":63,"zip":76,"country":65,"countryCode":66,"cosmosGeoPoint":77,"geoPoint":81,"contacts":43},"RECRUITING","South Pasadena","91030",{"type":68,"coordinates":78},[79,80],-118.15035,34.11612,{"lat":80,"lon":79},{"facility":60,"status":74,"city":83,"state":84,"zip":85,"country":65,"countryCode":66,"cosmosGeoPoint":86,"geoPoint":90,"contacts":43},"Miami","Florida","33165",{"type":68,"coordinates":87},[88,89],-80.19366,25.77427,{"lat":89,"lon":88},{"facility":60,"status":61,"city":92,"state":84,"zip":93,"country":65,"countryCode":66,"cosmosGeoPoint":94,"geoPoint":98,"contacts":43},"Tampa","33612",{"type":68,"coordinates":95},[96,97],-82.45843,27.94752,{"lat":97,"lon":96},{"facility":60,"status":61,"city":100,"state":101,"zip":102,"country":65,"countryCode":66,"cosmosGeoPoint":103,"geoPoint":107,"contacts":43},"Metairie","Louisiana","70006",{"type":68,"coordinates":104},[105,106],-90.15285,29.98409,{"lat":106,"lon":105},{"facility":60,"status":61,"city":109,"state":110,"zip":111,"country":65,"countryCode":66,"cosmosGeoPoint":112,"geoPoint":116,"contacts":43},"Minneapolis","Minnesota","55455",{"type":68,"coordinates":113},[114,115],-93.26384,44.97997,{"lat":115,"lon":114},{"facility":60,"status":61,"city":118,"state":119,"zip":120,"country":65,"countryCode":66,"cosmosGeoPoint":121,"geoPoint":125,"contacts":43},"Omaha","Nebraska","68130",{"type":68,"coordinates":122},[123,124],-95.94043,41.25626,{"lat":124,"lon":123},{"facility":60,"status":61,"city":127,"state":127,"zip":128,"country":65,"countryCode":66,"cosmosGeoPoint":129,"geoPoint":133,"contacts":43},"New York","10065",{"type":68,"coordinates":130},[131,132],-74.00597,40.71427,{"lat":132,"lon":131},{"facility":60,"status":61,"city":135,"state":136,"zip":137,"country":65,"countryCode":66,"cosmosGeoPoint":138,"geoPoint":142,"contacts":43},"Portland","Oregon","97239",{"type":68,"coordinates":139},[140,141],-122.67621,45.52345,{"lat":141,"lon":140},{"facility":60,"status":61,"city":144,"state":145,"zip":146,"country":65,"countryCode":66,"cosmosGeoPoint":147,"geoPoint":151,"contacts":43},"Houston","Texas","77030",{"type":68,"coordinates":148},[149,150],-95.36327,29.76328,{"lat":150,"lon":149},{"facility":60,"status":61,"city":153,"state":43,"zip":154,"country":155,"countryCode":156,"cosmosGeoPoint":157,"geoPoint":161,"contacts":43},"North Adelaide","5000","Australia","AU",{"type":68,"coordinates":158},[159,160],138.59141,-34.90733,{"lat":160,"lon":159},{"facility":60,"status":61,"city":163,"state":43,"zip":164,"country":165,"countryCode":166,"cosmosGeoPoint":167,"geoPoint":171,"contacts":43},"Essen","45147","Germany","DE",{"type":68,"coordinates":168},[169,170],7.01228,51.45657,{"lat":170,"lon":169},{"facility":60,"status":61,"city":173,"state":43,"zip":174,"country":165,"countryCode":166,"cosmosGeoPoint":175,"geoPoint":179,"contacts":43},"Jena","07747",{"type":68,"coordinates":176},[177,178],11.5899,50.92878,{"lat":178,"lon":177},{"facility":60,"status":61,"city":181,"state":43,"zip":182,"country":165,"countryCode":166,"cosmosGeoPoint":183,"geoPoint":187,"contacts":43},"Rostock","18057",{"type":68,"coordinates":184},[185,186],12.14049,54.0887,{"lat":186,"lon":185},{"facility":60,"status":61,"city":189,"state":43,"zip":190,"country":165,"countryCode":166,"cosmosGeoPoint":191,"geoPoint":195,"contacts":43},"Tübingen","72076",{"type":68,"coordinates":192},[193,194],9.05222,48.52266,{"lat":194,"lon":193},{"facility":60,"status":61,"city":197,"state":43,"zip":198,"country":199,"countryCode":200,"cosmosGeoPoint":201,"geoPoint":205,"contacts":43},"Bergamo","24127","Italy","IT",{"type":68,"coordinates":202},[203,204],9.66721,45.69601,{"lat":204,"lon":203},{"facility":60,"status":61,"city":207,"state":43,"zip":208,"country":199,"countryCode":200,"cosmosGeoPoint":209,"geoPoint":213,"contacts":43},"Meldola","47014",{"type":68,"coordinates":210},[211,212],12.0626,44.12775,{"lat":212,"lon":211},{"facility":60,"status":61,"city":215,"state":43,"zip":216,"country":199,"countryCode":200,"cosmosGeoPoint":217,"geoPoint":221,"contacts":43},"Milan","20133",{"type":68,"coordinates":218},[219,220],12.59836,42.78235,{"lat":220,"lon":219},{"facility":60,"status":61,"city":215,"state":43,"zip":223,"country":199,"countryCode":200,"cosmosGeoPoint":224,"geoPoint":226,"contacts":43},"20141",{"type":68,"coordinates":225},[219,220],{"lat":220,"lon":219},{"facility":60,"status":61,"city":228,"state":43,"zip":229,"country":199,"countryCode":200,"cosmosGeoPoint":230,"geoPoint":234,"contacts":43},"Roma","00168",{"type":68,"coordinates":231},[232,233],11.10642,44.99364,{"lat":233,"lon":232},{"facility":60,"status":61,"city":236,"state":43,"zip":237,"country":238,"countryCode":43,"cosmosGeoPoint":239,"geoPoint":243,"contacts":43},"Seoul","03080","South Korea",{"type":68,"coordinates":240},[241,242],126.9784,37.566,{"lat":242,"lon":241},{"facility":60,"status":61,"city":236,"state":43,"zip":245,"country":238,"countryCode":43,"cosmosGeoPoint":246,"geoPoint":248,"contacts":43},"03722",{"type":68,"coordinates":247},[241,242],{"lat":242,"lon":241},{"facility":60,"status":61,"city":236,"state":43,"zip":250,"country":238,"countryCode":43,"cosmosGeoPoint":251,"geoPoint":253,"contacts":43},"06351",{"type":68,"coordinates":252},[241,242],{"lat":242,"lon":241},{"facility":60,"status":61,"city":236,"state":43,"zip":255,"country":238,"countryCode":43,"cosmosGeoPoint":256,"geoPoint":258,"contacts":43},"06591",{"type":68,"coordinates":257},[241,242],{"lat":242,"lon":241},{"facility":60,"status":61,"city":236,"state":43,"zip":260,"country":238,"countryCode":43,"cosmosGeoPoint":261,"geoPoint":263,"contacts":43},"5505",{"type":68,"coordinates":262},[241,242],{"lat":242,"lon":241},{"facility":60,"status":61,"city":265,"state":43,"zip":266,"country":267,"countryCode":268,"cosmosGeoPoint":269,"geoPoint":273,"contacts":43},"Barcelona","08028","Spain","ES",{"type":68,"coordinates":270},[271,272],2.15899,41.38879,{"lat":272,"lon":271},{"facility":60,"status":61,"city":275,"state":43,"zip":276,"country":267,"countryCode":268,"cosmosGeoPoint":277,"geoPoint":281,"contacts":43},"L'Hospitalet de Llobregat","08908",{"type":68,"coordinates":278},[279,280],2.10028,41.35967,{"lat":280,"lon":279},{"facility":60,"status":61,"city":283,"state":43,"zip":284,"country":267,"countryCode":268,"cosmosGeoPoint":285,"geoPoint":289,"contacts":43},"Madrid","28031",{"type":68,"coordinates":286},[287,288],-3.70256,40.4165,{"lat":288,"lon":287},{"facility":60,"status":61,"city":283,"state":43,"zip":291,"country":267,"countryCode":268,"cosmosGeoPoint":292,"geoPoint":294,"contacts":43},"28041",{"type":68,"coordinates":293},[287,288],{"lat":288,"lon":287},{"facility":60,"status":61,"city":296,"state":43,"zip":297,"country":267,"countryCode":268,"cosmosGeoPoint":298,"geoPoint":302,"contacts":43},"Pamplona","31008",{"type":68,"coordinates":299},[300,301],-1.64323,42.81687,{"lat":301,"lon":300},{"facility":60,"status":61,"city":304,"state":43,"zip":305,"country":306,"countryCode":307,"cosmosGeoPoint":308,"geoPoint":312,"contacts":43},"Fulham","SW3 6JJ","United Kingdom","UK",{"type":68,"coordinates":309},[310,311],-0.1993,51.48026,{"lat":311,"lon":310},{"facility":60,"status":61,"city":314,"state":43,"zip":315,"country":306,"countryCode":307,"cosmosGeoPoint":316,"geoPoint":320,"contacts":43},"Guildford","CU2 7XX",{"type":68,"coordinates":317},[318,319],-0.57427,51.23536,{"lat":319,"lon":318},{"facility":60,"status":61,"city":322,"state":43,"zip":323,"country":306,"countryCode":307,"cosmosGeoPoint":324,"geoPoint":328,"contacts":43},"London","WC1E 6DB",{"type":68,"coordinates":325},[326,327],-0.12574,51.50853,{"lat":327,"lon":326},{"facility":60,"status":61,"city":330,"state":43,"zip":331,"country":306,"countryCode":307,"cosmosGeoPoint":332,"geoPoint":336,"contacts":43},"Newcastle upon Tyne","NE7 7DN",{"type":68,"coordinates":333},[334,335],-1.61396,54.97328,{"lat":335,"lon":334},{"facility":60,"status":61,"city":338,"state":43,"zip":339,"country":306,"countryCode":307,"cosmosGeoPoint":340,"geoPoint":344,"contacts":43},"Oxford","OX3 7LE",{"type":68,"coordinates":341},[342,343],-1.25596,51.75222,{"lat":343,"lon":342},{"type":346,"investigatorFullName":43,"investigatorTitle":43,"investigatorAffiliation":43,"oldNameTitle":43,"oldOrganization":43},"SPONSOR","100638391","phase-1-phase-ibii-platform-study-of-multiple-anti-cancer-agents-in-participants-with-metastatic-prostate-cancer-100638391",false,"NCT07590934","Phase Ib\u002FII Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer","A Phase Ib\u002FII, Open-label, Multi-centre, Platform Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Multiple Anti-Cancer Agents in Metastatic Prostate Cancer","PROSPECTOR","Inclusion Criteria:\n\n1. Participants with a diagnosis of histologically confirmed adenocarcinoma of the prostate (no small cell, neuroendocrine, sarcomatoid, spindle or signet cell).\n2. Minimum life expectancy of 3 months or more.\n3. Eastern Cooperative Oncology Group (ECOG) performance status of O or 1 at screening, with no deterioration.\n4. PCWG3 (Prostate Cancer Working Group 3) modified RECIST Version 1.1 evaluable disease.\n5. Must have received at least one novel androgen receptor pathway inhibitor (ARPI), such as enzalutamide or darolutamide or apalutamide or abiraterone acetate.\n6. Must have one or more unresectable metastatic lesions.\n7. Must have had prior orchiectomy and\u002For ongoing androgen deprivation therapy, and a castrate level of serum testosterone (\\\u003C50ng\u002FdL or \\\u003Cl.7nmol\u002FL).\n8. Progressive metastatic castration-resistant prostate cancer (mCRPC) following the most recent treatment at time of study entry.\n9. Adequate organ and marrow function.\n10. Non sterilised participants who are sexually active with a partner of childbearing potential must use a condom (plus spermicide, if available), must refrain from fathering a child, freezing or donating sperm, and it is recommended for the partner to also use a highly effective contraceptive method.\n\nInclusion Criteria for Sub study 1:\n\n1. Must have received a single line of ARPI, such as enzalutamide, darolutamide, apalutamide or abiraterone acetate.\n2. PSMA positive mCRPC by computed tomography positron emission tomography, obtained with PSMA ligand defined as at least 1 PSMA positive metastatic lesion with tracer uptake greater than liver, and no PSMA negative lesions. All measurable or intraprostatic lesions must be PSMA positive.\n3. Capable of self-administering oral formulations.\n\nExclusion Criteria:\n\n1. Any evidence of non adenocarcinomatous forms of prostate cancer (including small cell, spindle cell, signet cell, neuroendocrine, sarcomatous).\n2. Known, unresolved urinary tract obstruction.\n3. Participants with a history of central nervous system metastases.\n4. Symptomatic malignant spinal cord compression or findings indicative of impending cord compression.\n5. Participants with a history of leptomeningeal carcinomatosis.\n6. Previous or concurrent cancer distinct from the cancer under investigation in primary site or histology .\n7. Concurrent serious medical conditions.\n8. Previous history of interstitial lung disease or non-infectious pneumonitis.\n9. Participants with a history or clinical\u002Flaboratory features suggestive of myelodysplastic syndrome or acute myeloid leukaemia.\n10. Persistent toxicities caused by previous therapy.\n11. Participants unable to swallow orally administered medications or with gastrointestinal disorders likely to interfere with absorption.\n12. Active infection, including tuberculosis, hepatitis C virus, and hepatitis B virus infection.\n13. Known hypersensitivity to study intervention or any of their excipients.\n\nExclusion Criteria for Sub study 1:\n\n1. History of uncontrolled seizures or requirement for \\>2 antiepileptic drugs.\n2. History of severe brain injury or stroke.\n3. Skeletal metastases demonstrating a superscan appearance on bone scan.\n4. Participants have received prior therapy with AZD9574 or more than 1 prior line of any other Poly-ADP-ribose polymerase inhibitor (PARPi)-based regimen (either as a treatment or as maintenance).","MALE","18 Years","99 Years",{"count":359,"type":360},152,"ESTIMATED","INTERVENTIONAL",[363,364],"PHASE1","PHASE2","The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer.",[367],"Metastatic Prostate Cancer",[369,370,371,372,373,374],"Metastatic castration resistant prostate cancer","Prostate-specific membrane antigen-targeted radioligand therapy","Alpha particle therapy","Poly ADP-ribose polymerase 1 (PARP1) inhibitor therapy","Combination therapy","Docetaxel therapy","2026-06-29",{"date":377,"type":378},"2026-06-30","ACTUAL",{"date":380,"type":378},"2026-06-03",{"date":382,"type":360},"2029-09-25",{"name":5,"class":6},35]